Transcription of GOOD DISTRIBUTION PRACTICES (GDP) FOR …
{{id}} {{{paragraph}}}
Working document RESTRICTED WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE good DISTRIBUTION PRACTICES (GDP) FOR PHARMACEUTICAL PRODUCTS World Health Organization 2005 All rights reserved. This draft is intended for a restricted audience only, the individuals and organizations having received this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means outside these individuals and organizations (including the organizations concerned staff and member organizations) without the permission of WHO. The draft should not be displayed on any website. Please send any request for permission to: Dr Sabine Kopp, Quality Assurance & Safety: Medicines (QSM), Department of Medicines Policy and Standards (PSM), World Health Organization, CH-1211 Geneva 27, Switzerland.
Working document QAS/04.068/Rev.2 page 4 storage and distribution of such products. In some cases, however, a person or entity involved in the distribution of pharmaceutical products is only involved in and is responsible for certain
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Distribution 1A to, Products, Distribution Products, Good distribution practices for pharmaceutical, Distribution, Air Distribution and Venting Products, Smart solutions for electrical distribution, Finger-safe power distribution blocks, Cooper Industries, Distribution Statements, DISTRIBUTION AGREEMENT